Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)
Chronic obstructive pulmonary disease also called COPD, is a chronic lung disease that includes two main illnesses: chronic bronchitis and emphysema. ALRT has the only nebulizer monitoring system in the world. ALRT is directing its marketing efforts to this segment of the healthcare industry. One percent of the four million users of nebulizers would generate revenues of $19 million with a gross profit margin of approximately $14 million.
Considerable focus is being placed on the respiratory market due to the large number of people suffering from COPD who may have need for the ALRT nebulizer compliance and monitoring system.
There is no cure for COPD. This is a chronic and progressive disease which impacts the quality of a person’s life and activities in a dramatic fashion. Studies have indicated that it is not uncommon to find diagnosis of anxiety, depression and dyspnea associated with COPD. These associated issues such as depressions and anxiety are examples of the subtle but very real indicators which create barriers to medication compliance.
With the only nebulizer compressor monitoring system in the world ALR Technoligies’ system enables physicians and caregivers to monitor the patients or caretakers use of the nebulizer; the time of day used and the duration of time used. This monitoring is especially important to the millions of people who suffer from COPD and have to take nebulized medications daily. The system consists of the ALRT PC500 connected to nebulizer models that include the connectivity and a transmission modem. ALR Technologies has patents pending for this system.
Agreements have been reached with nebulizer manufacturers to produce nebulizer models containing the ALRT monitoring connectivity. An agreement with a specialty marketing company serving the respiratory market was completed that will provide access to the major respiratory marketing and provider companies.
Major home care networks are being targeted by the marketing company and the nebulizer manufacturers as channels of choice in providing the ALRT nebulizer compliance and monitoring system to physicians and their patients.
The respiratory market includes more than 16 million people with COPD. One of the methods for treating COPD is by inhaling drugs that are delivered through nebulizers, special machines that aerosolize drugs diluted in normal saline to permit easier inhalation into the lungs. There are four million nebulizer users who use nebulizers to deliver medication to their lungs three to four times every day. Nebulizer compliance is essential for maintaining quality of life and preventing rapid deterioration.
ALR Technologies Power Point Presentation.
Source: ALR Technologies
Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com
Sidney Chan, CEO
ALRT — ALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254
SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p
Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.
Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .